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ABSTRACT
Objectives: This article intends to understand how health risk is actually
valued and managed in public health programs through the case study of
the cancer plan in France.
Methods: A literature review has been carried out with a particular focus
on major health risk characteristics from a multidisciplinary perspective.
To assess the economic value of the cancer plan in France, the study uses
secondary data on the costs of cancer that have been collected and pub-
lished by the National Institute for Cancer for 2004.
Results: A model is designed to evaluate health risk components that can
be classiﬁed into four main categories relating the level at which risk is
analyzed (individual or population) to the main type of intervention
needed (preventive or curative) to cope with it. The ﬁndings show that
actions and interventions dealing with prevention, education, and research
represent 3.54% of the total costs of the cancer plan in France while
96.46% relates to health care and economic losses.
Conclusions: The proposed classiﬁcation of health risk components
gives more insight and understanding of risks associated with diseases
and illness and proposes an operational representation of actions and
costs related to the risks. The methodology proposed might be of sig-
niﬁcant interest to those involved in making health-care ﬁnancing
decisions.
Keywords: cost analysis, economic evaluation, public health, risk factors.
Introduction
The economic evaluation of public health programs derives from
methods based on their aggregate costs compared with their
efﬁcacy and future beneﬁts [1]. They do not take explicitly into
account the fundamental notion of health risk, which underpins
the goals and missions of public health policies. Yet, if preventing
illness and reducing diseases represent the major part of the
public health agenda [2], comprehensive public health plans
should focus mainly on health risk assessment and management
[3].
Moreover, evaluating public health systems [1] according to
their aggregate costs makes it difﬁcult to manage and monitor
ongoing public health programs [4] mainly because we must
adopt the principle that health requires more than just health
care [5]. Improvements in this sphere therefore require close
attention to the relationship between preventive and curative
measures and health-care policy intervention. In this context,
risk-targeted [6,7] approaches to economic evaluation represent
a promising avenue [8] through which to design, implement, and
monitor public health programs more effectively.
This contribution seeks to improve understanding of the ways
in which health risk is actually assessed and managed in public
health programs through a case study of the cancer plan in
France.
Methods
Multiparadigm Literature Review on Health Risk
A multidisciplinary review of the literature on risk was con-
ducted to explore how health risk is deﬁned, assessed, and
managed, particularly regarding its psychosocial aspects. The
academic EBSCO database (Business Source Premier, Cairn,
Elsevier, Factiva, Springer, Wiley, Blackwell; University of Mont-
pellier’s Library, France) was investigated ﬁrst of all for the
words “risk” and “health,” which yielded more than 15,000
results. A reﬁned search on “risk assessment” and “risk manage-
ment” yielded 164 articles published between 1973 and 2008. It
was particularly noteworthy in this regard to observe the tremen-
dous interest in the subject during the last years, because 87 of
these academic articles were published after 2004. In terms of
broad results, out of 164 articles, 16 concerned health risk assess-
ment, 12 risk communication, 9 public health, 7 evaluation, 6
medical care, and 7 methodology. A speciﬁc search for “health
risk” and “economic evaluation,” yielded ﬁve articles, out of
which only one [9] dealt with psychosocial considerations in
health evaluation. This search was completed by investigating
books and reports on public health and risk from the World
Health Organization (WHO) and the French Parliament.
The main objective of this literature review was to design a
conceptual framework in which the overall costs of a determined
public health program could be used to assess its value in terms
of health risk management.
Assessing the Economic Value of the Cancer Plan
in France
According to an accounting rationale, cancer plan costs can be
considered as the resources [10] devoted to addressing the risk of
cancer, either in terms of prevention or treatment. Then, to assess
the economic value of a public health plan it is critical to trans-
late costs into value. The question then is to determine on what
grounds costs can be an appropriate proxy for value in this
context? Costs represent the volume of resources spent to imple-
ment a health plan, while value is what population and individu-
als believe the plan is worth to them, i.e., the objectives of the
plan translated into health outcomes and health risk reduction.
In economic sectors where resource allocation is determined by
market forces, the value of economic goods can readily by deter-
mined by market prices compared to their costs; thus, the
decision-making process is based on the monetary proﬁt
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criterion. This approach can be adapted to decision-making in
the public sector using cost-efﬁciency or cost-utility evaluation
models based on anticipated costs and gains for the economy as
a whole. Nevertheless, Johansson [11] shows that, as a particular
public good [12,13], public health value cannot be simply
derived from market monetary rules. In this sector, economic
evaluation is dominated by cost-effectiveness analyses that
include health-related, nonmonetary measure (Johansson, p. 12).
Actually, in cost-effectiveness analyses, value and cost appear to
be closely imbricated [14], the main distinction rests on the fact
that monetary measure relates to costs and gains, while nonmon-
etary to health outcomes or value. Consequently, the decision
criterion must be based on benchmarking, either in comparison
to alternative interventions or to a threshold of costs per health
effect. Moreover, costs and value are not observable at the same
time; usually, costs are incurred before health outcomes are
observed. The discount rate applied to monetary measures is an
imperfect solution to this problem because of the nonmonetary
elements. A better solution would be to observe costs in a “lon-
gitudinal cost analysis” that would avoid cost-effectiveness
threshold biases. The value of health outcomes could then be
assessed by observing the evolution of cost structure in a histori-
cal perspective, given the objectives assigned to the public health
plan.
A detailed, densely documented investigation was carried out
by the National Institute for Cancer (INCA) [15] to collect all of
the costs incurred in France in relation to the ﬁght against cancer
in 2004. This survey covers the costs borne by the government
and the National Health Insurance system, along with those
borne by society, such as welfare and utility losses. This aspect
relating to lost production because of cancer had never previ-
ously been explored in France.
The overall costs of cancer are classiﬁed according to broad
topics: hospital and ambulatory care, production losses due to
cancer, public policy costs relating to prevention, screening, and
medical research. Health care costs were calculated from PMSI
(Programme de Médicalisation des Systèmes d’Information) data
(French medical database on the activity of public and private
hospitals, inspired by American DRGs [16]). Broader economic
and public databases, such as the national health account and the
government’s budget were used by the INCA to calculate other
costs. Total expenditure reached €11.924 billion, out of which
€10.886 billion was devoted to health care alone, €670 million to
medical research, €247.9 million to screening, and €120 million
to prevention campaigns. Prevention covers essentially the ﬁght
against tobacco and alcohol abuse, representing €109 million. In
addition to these accounting costs, opportunity costs for eco-
nomic losses corresponding to lost production and revenue were
estimated at nearly €17.5 billion based on net present value of
production losses and cost of sick leave.
Results
Literature Review: Modeling Health Risk
As a multidisciplinary ﬁeld of study, Health Economics draws on
welfare and microeconomics, biostatistics, epidemiology, and
many other disciplines [17]; thus, health risk assessment should
encompass all of these aspects. The literature review carried out
shows that the risk conceptualization proposed by economists
[18]may help articulate an epistemological approach to risk based
on different paradigms, because it distinguishes uncertainty that
cannot be anticipated or controlled from risk that can be modeled
and predicted [19]. In this way, risk modeling may be seen as an
attempt to control the unknown by applying knowledge to uncer-
tainty: Each discipline can apply its own particular form of
knowledge [20] to chance, to convert it into a risk proposition. It
follows that the concept of risk is multifaceted [21] and requires
investigation from a multidisciplinary [22,23] perspective.
Science and medicine understand and deﬁne risk as an objec-
tive reality that can be measured, controlled, and managed [24].
Risk is an impending epidemic or disease, an environmental
disaster or a safety catastrophe, that can be harnessed by apply-
ing our knowledge to uncover the facts and putting remedial
action or anticipatory measures into place. Social sciences stress
the subjective nature of risk vis-à-vis the objective scientiﬁc view
[25]. Psychology is preoccupied with determining the discrep-
ancy between expert and every-day risk perception [26]; it
assesses the reasons for being risk-averse, risk-indifferent, or a
risk-taker [27], and aspects of motivation and cognition that
characterize risk behavior. Sociology argues that the dominant
scientiﬁc paradigm is breaking down, creating an opportunity for
politics to determine the deﬁnition and treatment of risk. In
reality, the sociological literature on risk is an eclectic patchwork
[28], in which the sociocultural perspective constitutes an
attempt to marry anthropology, society, and governmental
action, to produce a synthesis through which to understand risk
as a societal phenomenon [29]. Risk and society are intertwined
and we must turn to people and the societies in which they live to
understand risk. Some research [30] has shown that the way
people respond to illness and its risks depends on their education,
their age and their profession.
Among these approaches, the philosophical viewpoint [31]
appears to be the more comprehensive, because it provides an
epistemological approach to viewpoints on risk proposed by
other disciplines. The philosophical approach [13] identiﬁes ﬁve
different types of risks:
1. “subjective risk: the mental state of an individual who expe-
riences uncertainty or doubt or worry as to the outcome of
a given event;
2. objective risk: the variation that occurs when actual losses
differ from expected losses;
3. real risk: the combination of probability and negative con-
sequences that exists in the real world;
4. observed risk: the measurement of that combination
obtained by constructing a model of the real world; and
5. perceived risk: the rough estimate of real risk made by an
untrained member of the general public.” (p. 568)
These deﬁnitions can be classiﬁed according to two ration-
ales, the ﬁrst of which distinguishes individual (subjective, objec-
tive, perceived) from collective (real, observed) characteristics of
risk; while the second differentiates risk deﬁned as a reality that
exists in its own right (objective, observed) from risk deﬁned as
a reality by virtue of a judgment (subjective, perceived, real). On
the basis of these two rationales, two dimensions for analyzing
risk components may be identiﬁed.
When applied to health risk, this conceptual scheme allows
for the classiﬁcation of the different interventions and actions
which constitute a public health program (Fig. 1). The ﬁrst axis
represents individual and population approaches to health risk. It
distinguishes preventive and curative care at the individual level
from public health actions and economic consequences of illness
at the population level. The second axis differentiates between
interventions designed to prevent diseases and those undertaken
when diseases have occurred. These two axes delineate four
quartiles corresponding to the categories of actions and interven-
tions for each component of health risk, as shown in Figure 1.
Real health risk relates to illness as a social process affecting
social structure and organization. It refers more speciﬁcally to
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health risks engendered by life style and culture. In this context,
it is essential to identify health risk factors to put in place the
main actions that are required within society with regard to
education and prevention. The notion of risk factor in the socio-
economic approach emphasizes that risk-taker decisions result
from a complex system of interactions, which must be investi-
gated through longitudinal studies [32]. For instance, the corre-
lation between a risky decision and the satisfaction expected by
the risk taker depends on the measurement system: correlation is
positive when risk is evaluated according to its potential gains
and negative according to its potential losses. Public health pro-
grams must therefore include research and survey data, informa-
tion campaigns, and health promotion measures.
Observed health risk encompasses the economic consequences
of illness, such as production losses borne by society through the
working days lost and their impact on the functioning of public
and private organizations that will have to compensate for such
losses through corrective actions. Even though this implicit dimen-
sion of the costs of illness is very often underestimated, it is a real
burden from the economic and social viewpoint.
Subjective/perceived health risk points to the way an indi-
vidual reacts to illness, as far as identity construction [18] is
concerned. This risk depends on individual behaviors when con-
fronted with illness. Actions to cope with this risk focus mainly
on prevention at the individual level, such as screening, counsel-
ing, disease detection, disease management.
Objective health risk relates to the effects of illness on the
physical and mental health that must be treated by the health-
care system, namely primary care, hospital outpatient care, and
clinical care.
Assessing the Economic Value of the Cancer Plan
in France
The model outlined in Figure 1 has been applied to the cancer
plan, drawing data from the study carried out by the INCA on
the costs of cancer in France (Table 1).
Figure 2 classiﬁes the costs detailed in Table 1 according to
the four health risk components previously deﬁned. It appears
that public health actions and interventions (real risk and sub-
jective risk) represent 3.54% of the total resources devoted to the
plan; 96.5% of these resources were devoted to compensating for
the consequences of illness (objective risk and observed risk).
This ﬁnding reveals a reactive type of public health system that
concentrates on curative care and clearly understates prevention.
The majority of the resources engaged in the cancer plan, i.e.,
almost 60% of the total, are intended to deal with the observed
health risk. This result underlines the real issue concerning public
INDIVIDUAL 
Level of 
analysis
Type of 
intervention
POPULATION 
PREVENTION CURATIVE CARE 
REAL HEALTH RISK OBSERVED HEALTH RISK 
SUBJECTIVE/ 
PERCEIVED HEALTH RISK 
OBJECTIVE HEALTH RISK 
- Research & studies 
- Information campaigns 
- Health promotion 
- Production losses 
- Sick leaves 
- Screening & counseling 
- Disease detection 
- Disease management 
- Primary care 
- Hospital outpatient care  
- Clinical care 
Figure 1 Public health actions/interventions
according to health risk components.
Table 1 The costs of cancer in France (2004) (Source: INCA, 2007)
Cost items
Valuation
(K€ except item 1)
1. Impact of illness on life years
Potential life-years lost About 2,300,000
2. Health-care costs 10,886,190
Clinical care 7,184,885
Ambulatory care 3,701,305
3. Production losses 17,448,881
Productivity losses due to sick leaves, evaluated by
the “friction cost” method
527,811
Potential production losses due to mortality,
evaluated by the “discounted wages” method (or
human capital).
16,921,070
4. Primary care prevention (information campaigns) 120,000
Tobacco 46,000
Alcohol 63,000
Food/physical training 11,000
5. Screening and disease detection 247,900
Breast cancer 194,200
Colon cancer 53,700
6. Public funded research 670,000
Government funding to research bodies and
universities
324,000
National Health Insurance funding to hospitals 302,000
Public funding to research contracts on cancer 44,000
Value in italic indicate category totals.
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health policies centered on prevention and education, where
emphasis is placed, not on containing and controlling costs, but
on avoiding production and value losses borne by the economic
system because of illness.
Discussion
The model proposed makes it possible to go beyond an “aggre-
gate costs” logic in the evaluation of public health programs.
Implementation of the model is based on the fact that in the case
of public health programs, value is derived from cost structure.
Indeed, it is the cost-mix obtained from the risk components that
reﬂects the value of a public health plan. As a corollary, the value
of a public health plan can be assessed through the risk-
component-mix. To go beyond the operational aspect of the
model proposed, further research should try to formalize the
relationship between these two variables.
In the case of the French cancer plan, the model makes it
possible to split the total cost of €29.373 billion. The evaluation of
cancer risk through the model of health risk components conﬁrms
that the national health system is directed toward themanagement
of the objective risk, i.e., curative care at the individual level. This
explains why the political debate on health-care ﬁnancing gener-
ally underestimates organizational and institutional settings that
are essential for a comprehensive management of health risk. This
approach is crucial for chronic diseases that need to be studied and
managed adopting a life-course model.
Implications for the management of risk and uncertainty in
health and illness are twofold. First, actions and interventions
can be classiﬁed according to the level at which health risk is
analyzed, i.e., individual or population level on the one hand,
and the type of action/intervention needed to cope with each
particular aspect of risk on the other hand. When real and
subjective/perceived risks are undervalued in favor of objective
and observed risks, the value of the plan is low as far as risk
management is concerned. Second, each action/intervention can
be linked to the whole set of measures making up the program.
In this way, it becomes possible to measure the relationships
between the different aspects of public health policies and their
future outcomes.
Much of the available data on health care is reported accord-
ing to separate “silos” of care provision: ambulatory care versus
hospital inpatient care, consumption of pharmaceuticals versus
other medical goods. This makes the comparative analysis of
health care for the chronically ill particularly challenging,
because these patients tend to use multiple health-care resources
for the treatment of their conditions. Opportunities to link these
data domains are usually limited. Taking a piecemeal approach
to performance measurement is likely to be suboptimal.
Given the fact that most public health programs today are
dedicated to remedying the damage preceded by earlier depriva-
tions, an important and logical question to ask would be: What
interventions can be instituted to slow down the progression of
earlier adverse effects and reverse any potential damage? By
systematically pursuing a life-course paradigm, we could poten-
tially reduce the heavy human and economic costs precipitated
by health inequities. The knowledge gained from life-course
studies could then be resolutely applied to health and other
programs in different age, racial/ethnic, socioeconomic, and
gender groups to relieve suffering and offer hope of living healthy
and fulﬁlling lives [33]. Engaging in such studies requires cohe-
sive national planning, vast amounts of resources, and substan-
tial commitments to thoughtfully analyzing and disseminating
collected data that can be facilitated by the proposed conceptual
model of health risk. Therefore, the model represents a powerful
tool for the coordination of public health actions in a longitudi-
nal approach.
From the public health policy perspective, plan evaluation
through the model of health risk components will provide an
answer to questions such as what strong primary care systems
entail and what consequences strong primary care systems have
on the performance of overall health-care systems. According to
the WHO [34], health systems have three fundamental objec-
tives: ﬁrst, to achieve an improvement in the health status of the
population; second, to respond to people’s expectations about
their health; third, to provide ﬁnancial protection against the
INDIVIDUAL 
Level of 
analysis
Type of 
intervention
POPULATION 
PREVENTION CURATIVE CARE 
Information campaigns 
and public funded 
research: 790 000K• 
Production losses: 
17 448 881 K•
Screening and disease 
detection: 247 900 K• 
Health care:
10 886 190 K•
2.70% 59.40% 
0.84% 37.06% 
REAL HEALTH RISK OBSERVED HEALTH RISK 
SUBJECTIVE/ 
PERCEIVED HEALTH RISK 
OBJECTIVE HEALTH RISK 
Figure 2 Value of the different components of
cancer risk in France (Data source: INCA 2007,
France).
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costs of ill-health. To implement health systems responding to
such objectives, it is necessary to highlight the determinants of
the relationship between outcomes and costs through the concept
of risk management.
Primary care physician supply is regularly associated with
improved health outcomes for conditions like cancer, heart
disease, stroke, infant mortality, low birth weight, life expect-
ancy, and self-rated care [35].An orientation in favor of primary
care reduces socio-demographic and socioeconomic disparities.
When adults have recourse to primary care, they have access to
preventive screenings [36], and management of frequent chronic
conditions results in fewer complications, leading to fewer avoid-
able hospitalizations [37].
Although health-care expenditure continues to rise (up to 11%
of gross domestic products in some EU countries), the needs of
patient groups such as the elderly and chronically ill are still not
adequately met. The increasing complexity of health care needs in
speciﬁc patient groups, such as the elderly and the chronically ill,
challenges the provision of adequate, population-based health-
care services. We still lack deﬁnite answers to fundamental ques-
tions: What are the determinants of better performance? How
does the relationship operate between higher quality aspects of
health care and its impact on costs? What is the potential risk
associated with the less expensive health-care models?
From the corporate perspective, the primary goal is to protect
the employer against ﬁnancial loss due to illness, disability, and
reduced productivity among the workforce. Implementation of a
program to meet this objective consists of a four-step process: 1)
identify the health risks of the employee population; 2) assess the
level of risk of each health factor for each employee as well as the
entire employee group; 3) determine the ﬁnancial impact of the
risk; and 4) develop a risk-reduction strategy consisting of pro-
grams and interventions that will realize quantiﬁable net savings.
Source of ﬁnancial support: None.
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